![Christina Trojel-Hansen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Christina Trojel-Hansen is the founder of Oscine Corp.
She previously worked as a Senior Associate at Novo Seeds from 2016 to 2018.
Antiguos cargos conocidos de Christina Trojel-Hansen.
Empresas | Cargo | Fin |
---|---|---|
Oscine Corp.
![]() Oscine Corp. BiotechnologyHealth Technology Oscine Corp. engages in the development of cell therapies for diseases of the brain and central nervous system (CNS). It offers cell platform that generates bi-potential astrocyte-oligodendrocyte glial progenitor cells. The company was founded by Steven Alan Goldman and Christina Trojel-Hansen and is headquartered in Rochester, NY. | Director Ejecutivo | 01/09/2020 |
Novo Seeds
![]() Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Analista de Capital Privado | 01/04/2018 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Novo Seeds
![]() Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Finance |
Oscine Corp.
![]() Oscine Corp. BiotechnologyHealth Technology Oscine Corp. engages in the development of cell therapies for diseases of the brain and central nervous system (CNS). It offers cell platform that generates bi-potential astrocyte-oligodendrocyte glial progenitor cells. The company was founded by Steven Alan Goldman and Christina Trojel-Hansen and is headquartered in Rochester, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Christina Trojel-Hansen